Healthcare / Medical Care FacilitiesUpdated 2026-05-10 22:07 UTC

NUTX stock hub

Nutex Health Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NUTXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

940.4M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

NUTX

In the news

Latest news · NUTX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E6.4

P25 12.3P50 18.4P75 33.1

Trailing P/E9.9

P25 14.9P50 23.2P75 38.5

ROE53.6

P25 -105.6P50 -46.5P75 -3.1

ROIC51.5

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NUTX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

245

Groups with data

Currency

USD

Showing 245 of 245 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001479681
Company name	Nutex Health Inc.
Country	United States
Country code	US
Cusip	67079U306
Employees	1,005
Employees Change	61%
Employees Change Percent	6.46
Enterprise value	$1.1B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Care Facilities
Isin	US67079U3068
Last refreshed	2026-05-10
Market cap	$940.4M
Market cap category	Small-Cap
Price	$137
Price currency	USD
Rev Per Employee	875,575.12x
Sector	Healthcare
Sic	7389
Symbol	NUTX
Website	https://www.nutexhealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	10.25%
EV Earnings	11.23x
EV Sales Forward	1.55x
EV/EBIT	2.75x
EV/EBITDA	2.61x
EV/FCF	4.09x
EV/Sales	1.23x
FCF yield	28.15%
Forward P/E	6.39x
P/B ratio	2.74x
P/E ratio	9.86x
P/S ratio	1.07x
PS Forward	1.35x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	44.69%
EBITDA Margin	47.07%
FCF margin	30.08%
Gross margin	50.58%
Gross Profit	$445.1M
Gross Profit Growth	34.91%
Gross Profit Growth Q	-21.23%
Gross Profit Growth5 Y	50.9%
Net Income	$96.4M
Net Income Growth	30.81%
Net Income Growth Q	120.61%
Net Income Growth Quarters	1%
Net Income Growth Years	3%
Net Income Growth5 Y	35.73%
Pretax Margin	28.42%
Profit Margin	10.95%
Profit Per Employee	$95,900
Profitable Years	2
ROA	28.59
Roa5y	15.51
ROCE	50.88
ROE	53.65
Roe5y	-18.36
ROIC	51.55
Roic5y	27.6

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	16.4%
Cagr3y	20.4%
EPS Growth	8.74
EPS Growth Q	95.9
EPS Growth Quarters	1
EPS Growth Years	3
FCF Growth	281.24%
FCF Growth Q	46%
FCF Growth3 Y	263.74%
OCF Growth	283.69%
OCF Growth Q	48.18%
OCF Growth3 Y	157.78%
OCF Growth5 Y	86.38%
Revenue Growth	40.95x
Revenue Growth Q	2.22x
Revenue Growth Quarters	1x
Revenue Growth Years	3x
Revenue Growth3 Y	64.83x
Revenue Growth5 Y	55.41x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.02
Assets	$957.3M
Cash	$207.3M
Current Assets	$579.6M
Current Liabilities	$184.4M
Debt	$349.1M
Debt EBITDA	$0.83
Debt Equity	$0.79
Debt FCF	$1.32
Equity	$442.1M
Interest Coverage	18.92
Liabilities	$515.3M
Long Term Assets	$377.7M
Long Term Liabilities	$330.8M
Net Cash	$-141.7M
Net Cash By Market Cap	$-15.07
Net Debt EBITDA	$0.34
Net Debt Equity	$0.32
Net Debt FCF	$0.54
Tangible Book Value	$311.5M
Tangible Book Value Per Share	$44.81
WACC	12.63

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.14
Inventory Turnover	111.5
Net Working Capital	$214.3M
Quick ratio	3
Working Capital	$395.2M
Working Capital Turnover	$2.84

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-17.75%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	16.39%
200-day SMA	117.3
3Y total return	74.57%
50-day SMA	105.9
50-day SMA vs 200-day SMA	50under200
All Time High	7,920
All Time High Change	-98.27%
All Time High Date	2022-04-04
All Time Low	4.16
All Time Low Change	3,185.1%
All Time Low Date	2024-07-10
ATR	10.33
Beta	2.07
Beta1y	2.49
Beta2y	2.11
Ch YTD	-16.98
High	138.5
High52	193.1
High52 Date	2025-12-30
High52ch	-29.22%
Low	131
Low52	77.21
Low52 Date	2025-09-02
Low52ch	77%
Ma50ch	29.1%
Price vs 200-day SMA	16.54%
RSI	62.45
RSI Monthly	44.38
RSI Weekly	56.05
Sharpe ratio	0.61x
Sortino ratio	0.96
Total Return	-17.75%
Tr YTD	-16.98
Tr1m	32.81%
Tr1w	-2.08%
Tr3m	36.8%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Count Top	1
Analyst Price Target Top	$300
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$5.56
Earnings EPS Estimate Growth	117.2
Earnings Revenue Estimate	227,800,810x
Earnings Revenue Estimate Growth	7.56x
Operating Income	$393.2M
Operating Income Growth	81.22
Operating Income Growth Q	0.75
Operating Income Growth5 Y	62.49
Operating margin	44.69
Price target	$253
Price Target Change	$84.77
Price Target Change Top	$120

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,630,641%
Float Percent	52.76%
Net Borrowing	-23,693,000
Shares Insiders	31.54%
Shares Institutions	25.62%
Shares Out	6,881,339
Shares Qo Q	1.53%
Shares Yo Y	17.75%
Short Float	26.35%
Short Ratio	5.23
Short Shares	13.9

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$179.3M
Average Volume	203,817.35x
Bv Per Share	49.81
CAPEX	$-8M
Ch1m	32.81
Ch1w	-2.08
Ch1y	16.39
Ch3m	36.8
Ch3y	74.57
Ch6m	19.2
Change	1.54%
Change From Open	1.76
Close	134.6
Days Gap	-0.22
Depreciation Amortization	20,930,000
Dollar Volume	14,202,663.8
Earnings Date	2026-04-30
Earnings Time	amc
EBIT	$393.2M
EBITDA	$414.2M
EPS	$13.86
F Score	5
FCF	$264.7M
FCF EV Yield	24.46x
FCF Per Share	$38.47
Financing CF	-140,686,000
Fiscal Year End	December
Founded	2,011
Goodwill	13,919,000
Graham Number	124.62462
Graham Upside	-8.81
Income Tax	$57.8M
Investing CF	-6,379,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Last Split Date	2024-07-03
Last Split Type	Reverse
Last10k Filing Date	2026-03-05
Lynch Fair Value	$346
Lynch Upside	153.5
Ma150	125.4
Ma150ch	8.97%
Ma20	116.9
Ma20ch	16.88%
Net CF	125,613,000
Next Earnings Date	2026-11-17
Open	134.3
Optionable	No
P FCF Ratio	3.55
P OCF Ratio	3.45
Position In Range	75.63
Post Close	136.7
Postmarket Change Percent	1.53
Postmarket Price	$139
Ppne	342,177,000
Price Date	2026-05-08
Price EBITDA	$2.27
Ptbv Ratio	3.02
Relative Volume	0.51x
Revenue	879,953,000x
SBC By Revenue	9.71x
Share Based Comp	85,446,000
Tax By Revenue	6.57x
Tax Rate	23.11%
Tr6m	19.2%
Us State	Texas
Volume	103,927
Z Score	3.28

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NUTX pay a dividend?

Capital-return profile for this ticker.

Performance

NUTX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NUTX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+25.6%

Float: +52.8% of shares outstanding

Insider ownership

+31.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

NUTX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

62.5

Neutral momentum band

Price vs 200-day MA

+16.5%

50/200-day relationship not available

Beta (5Y)

2.07

More volatile than the market

Sharpe ratio

0.61

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NUTX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current NUTX stock rating?

Nutex Health Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full NUTX analysis?

The full report lives at /stocks/NUTX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for NUTX?

The latest report frames NUTX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the NUTX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.